Delivery Order SPE2DR25D7058-SPE2DR26F8DJB
- Not listed
- The Defense Logistics Agency (DLA) awarded a $7,941.41 delivery order to AmerisourceBergen Drug Corp for HYZAAR 100-12.5 tablets (90-count units) on July 30, 2025, with completion targeted for July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical supply requirement supporting federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $15,164.14 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets (30 count) under a firm fixed price contract type. This delivery order, issued on August 29, 2025, with an ultimate completion date of September 2, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of HYZAAR 50-12.5 mg tablets (30-count units) valued at $1,549.20. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by October 29, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,596.31 to AmerisourceBergen Drug Corp for the supply of HYZAAR 100-12.5 mg tablets (30-count units), with an ultimate completion date of January 5, 2026. This non-set-aside, competitively awarded contract employs firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (a combination antihypertensive medication) in the quantity of 30 units, with a ceiling value of $1,059.30. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract is classified as a child award, indicating it derives from a larger contract vehicle. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $2,889.30 delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablet medication (30-count supply), with an ultimate completion date of July 24, 2025. This is a firm fixed-price, non-set-aside contract performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving the federal medical procurement sector, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $5,776.16 to AmerisourceBergen Drug Corp for the supply of HYZAAR 50-12.5 tablets in quantities of 30, with a firm fixed price contract type and an ultimate completion date of December 9, 2025. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The contract was...
- The Defense Logistics Agency awarded a $3,928.00 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HYZAAR 50-12.5 tablets (30 count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a non-set-aside, competitively awarded contract supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of HYZAAR 50-12.5 tablets (30-count units) valued at $2,083.81, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive global...
- The Defense Logistics Agency awarded a $2,155.66 delivery order to AmerisourceBergen Drug Corp for 90 tablets of HYZAAR 100-12.5, a combination antihypertensive medication, with an ultimate completion date of August 28, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued on August 27, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- SPE2DR25D7058Indefinite Delivery Contract
- SPE2DR25D7058-SPE2DR26F8DJBDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for supply of HYZAAR 50-12.5 tablets in quantities of 30 units, with a contract ceiling value of $2,027.66. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and carries an ultimate completion date of November 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location in the same city. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and running through December 2026. The IDC supports military healthcare programs globally and enables the contractor to supply a broad range of pharmaceutical products, including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. As a critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contracting vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 11/25/25 |